HKSE · 1110.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Kingworld Medicines Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Kingworld Medicines Group Limited’s forward annual dividend is HK$0.03 per share, paid annual. The forward yield is 8.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kingworld Medicines Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health goods, and general food items. Its extensive product catalog caters to various therapeutic areas, such as respiratory relief (for cough and phlegm), gastrointestinal issues, vitamin supplementation, orthopedic support, cardiovascular health, and influenza care. Key brands distributed include Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, the Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and the Mentholatum Product Range. Furthermore, Kingworld is involved in the production and sale of electrotherapeutic and physiotherapeutic devices, as well as common medical examination equipment. Its market presence spans the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and other international regions. The company, founded in 1996, is headquartered in Shenzhen, PRC.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
HK$1.57-HK$0.01 (-0.32%)
Mediwelcome Healthcare Management & Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.84% below the high.
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
HK$0.37HK$0.00 (0.0%)
UMP Healthcare Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 27.0% below the high.
HK$0.76+HK$0.01 (+0.66%)
Human Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
HK$0.57HK$0.00 (0.0%)
Arts Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 48.18% below the high.
HK$0.25+HK$0.00 (+0.82%)
Tycoon Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
HK$0.09HK$0.00 (0.0%)
Tianda Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
HK$0.03HK$0.00 (0.0%)
Tai United Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
